Optimizing Disability Benefit Decisions and Outcomes in First Episode Psychosis
优化首发精神病中的残疾福利决策和结果
基本信息
- 批准号:10521916
- 负责人:
- 金额:$ 78.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-09 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:AffectAgeAttentionAwardBlack AmericanCOVID-19 pandemicCaliforniaCharacteristicsClientClinicalCommunitiesComplexConsolidated Framework for Implementation ResearchCoordinated Specialty CareDataData CollectionData SetDecision MakingDeteriorationDevelopmentDisincentiveEconomicsEmploymentEnrollmentEvaluationEvidence based practiceFeedbackFundingGenerationsGoalsImpairmentIndependent LivingIndividualInterruptionInterventionInterviewKnowledgeLearningLinkMedicaidMedicare/MedicaidMental Health ServicesMethodsMinorityModelingMotivationNational Institute of Mental HealthNew YorkOutcomePartnership PracticePennsylvaniaPersonsPlayPoliciesPopulationPovertyProcessPsychosesPsychotic DisordersRaceRecoveryResearchResearch PersonnelRoleSchizophreniaSchoolsService delivery modelServicesShockSiteSocial SecurityStructural RacismSurveysTexasTimeTranslational ResearchUnited StatesUnited States Social Security AdministrationWorkYouthagedcare recipientscare systemscareer developmentdesigndisabilitydisability impactearly psychosisevidence baseexperiencefirst episode psychosisimplementation strategyimprovedimproved outcomeinnovationminority childrenpreventprogramsracial differenceracial discriminationracial disparityracial identityresearch to practicesocialsocial determinantssocial influencesociodemographicsyoung adult
项目摘要
A major NIMH goal for early psychosis treatment is to “prevent deterioration and disability among
individuals suffering from psychotic illness”. However, rates of Social Security Administration disability (SSI/DI)
enrollment remain high for young people in early psychosis treatment. Existing studies on SSI/DI have limited
information on the FEP population. Enrollment in SSI/DI may provide benefits (including cash assistance,
access to Medicaid/Medicare, and other social entitlements), but also detrimentally impact identity, vocational
aspirations, career development and employment; individuals rarely leave SSAD benefits for full-time work.
Racial disparities have also been identified, but remain poorly understood, with respect to the intersections
between race, structural racism and the poorer outcomes long-documented among ethnoracialized minorities,
particularly Black Americans. It is crucial to generate knowledge with the potential to inform decision-making
about the benefits and trade-offs inherent in SSI/DI participation and help optimize outcomes within the context
of SSI/DI participation among this population of young people (e.g. generally aged 16-30).
The primary goal of this project is to investigate factors influencing decisions to apply for SSI/DI, the
impact of these decisions, and the longitudinal relationships between SSI/DI and career development. This
information will then be used to develop systematic strategies for improving services, supporting client decision
making and optimizing outcomes.
The NIMH-funded Early Psychosis Intervention Network (EPINET), spanning 105 coordinated specialty
care (CSC) programs across 16 states, affords an exceptional opportunity to better understand these issues.
Leveraging the EPINET initiative, this multi-phase, mixed methods study will provide important new knowledge
regarding predictors of application and the relationship between SSI/DI and vocational functioning, will facilitate
development and evaluation of a multi-level menu of actionable targets and associatedimplementation
strategies, for example, specific ways of improving programmatic supports and policy changes designed to
strengthen SSAD-related outcomes (translation of research to practice). The project is guided by the multi-level
Disability Creation Process (DCP2) framework, and implementation activities by the Consolidated Framework
for Implementation Research (CFIR). The proposed project will utilize quantitative data from the EPINET
common dataset (n=5000), supplemented with primary quantitative (n = 330) and qualitative (n = 110) data
collection in four distinct states. The study aims are to: determine the extent and predictors of SSI/DI
application, SSAD enrollment and work/school functioning among clients enrolled in CSC programs,
systematically investigate the client experience of SSI/DI decision making (through quantitative and qualitative
data) and using implementation mapping to develop strategies to optimize CSC services as they impact
SSI/DI. Racial differences and potential disparities will be examined across all three Aims.
早期精神病治疗的主要NIMH目标是“防止细节和残疾
但是,患有精神病的人”。但是,社会保障局残疾的率(SSI/DI)
在早期精神病治疗中,年轻人的入学人数仍然很高。现有关于SSI/DI的研究有限
有关FEP人群的信息。 SSI/DI的注册可能会提供福利(包括现金援助,
获得医疗补助/医疗保险以及其他社会权利),但也会对身份有害,投票
愿望,职业发展和就业;个人很少为全职工作留下SSAD福利。
还已经确定了种族分布,但在交叉点方面仍然很了解
在种族,结构性种族主义和在民族化少数民族中长期以来的较差成果之间,
特别是黑人美国人。产生知识的潜力至关重要
关于SSI/DI参与中固有的利益和权衡,并有助于在上下文中优化结果
SSI/DI在这一年轻人中的参与(例如,通常年龄在16-30岁)。
该项目的主要目标是研究因素影响申请SSI/DI的决策,
这些决定的影响以及SSI/DI与职业发展之间的纵向关系。这
然后,信息将用于制定改善服务的系统策略,支持客户决策
制定和优化结果。
NIMH资助的早期精神病干预网络(EPITSET),跨越105个配位专业
跨16个州的CARE(CSC)计划为更好地理解这些问题提供了一个特别的机会。
利用该倡议,这项多相混合方法研究将提供重要的新知识
相关的应用预测因素以及SSI/DI与职业功能之间的关系,将有助于
多级可行的目标和关联菜单的开发和评估
例如,策略,改善了旨在改善程序化支持和政策更改的特定方法
加强与SSAD相关的结果(将研究翻译成实践)。该项目以多层次为指导
残疾创建过程(DCP2)框架和通过合并框架实施活动
用于实施研究(CFIR)。拟议的项目将利用Epatet的定量数据
常见数据集(n = 5000),补充了主要定量(n = 330)和定性(n = 110)数据
在四个不同的状态中收集。该研究的目的是:确定SSI/DI的程度和预测指标
在参加CSC计划的客户中,应用程序,SSAD注册和工作/学校功能,
系统地研究SSI/DI决策的客户体验(通过定量和定性
数据)并使用实施映射来制定策略以优化CSC服务,以便它们影响它们
SSI/DI。种族差异和潜在差异将在所有三个目标中进行检查。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LISA B. DIXON其他文献
LISA B. DIXON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LISA B. DIXON', 18)}}的其他基金
Examining the effectiveness of a shared decision making intervention for antipsychotic medications to improve engagement in treatment for people experiencing early psychosis
检查抗精神病药物共同决策干预的有效性,以提高早期精神病患者的治疗参与度
- 批准号:
10670896 - 财政年份:2022
- 资助金额:
$ 78.76万 - 项目类别:
Examining the effectiveness of a shared decision making intervention for antipsychotic medications to improve engagement in treatment for people experiencing early psychosis
检查抗精神病药物共同决策干预的有效性,以提高早期精神病患者的治疗参与度
- 批准号:
10510009 - 财政年份:2022
- 资助金额:
$ 78.76万 - 项目类别:
Adapting Coordinated Specialty Care in the Post COVID-19 Era
在后 COVID-19 时代调整协调专业护理
- 批准号:
10193474 - 财政年份:2019
- 资助金额:
$ 78.76万 - 项目类别:
Zero Suicide Implementation and Evaluation in Outpatient Mental Health Clinics
门诊心理健康诊所零自杀实施与评估
- 批准号:
10572128 - 财政年份:2016
- 资助金额:
$ 78.76万 - 项目类别:
Improving Life Trajectories for Youth with Early Psychosis
改善早期精神病青少年的生活轨迹
- 批准号:
8916281 - 财政年份:2014
- 资助金额:
$ 78.76万 - 项目类别:
Randomized Trial of a Smoking Cessation Program for Persons with SMI
SMI 患者戒烟计划的随机试验
- 批准号:
8195952 - 财政年份:2009
- 资助金额:
$ 78.76万 - 项目类别:
Randomized Trial of a Smoking Cessation Program for Persons with SMI
SMI 患者戒烟计划的随机试验
- 批准号:
8392115 - 财政年份:2009
- 资助金额:
$ 78.76万 - 项目类别:
Randomized Trial of a Smoking Cessation Program for Persons with SMI
SMI 患者戒烟计划的随机试验
- 批准号:
7916627 - 财政年份:2009
- 资助金额:
$ 78.76万 - 项目类别:
Randomized Trial of a Smoking Cessation Program for Persons with SMI
SMI 患者戒烟计划的随机试验
- 批准号:
7786750 - 财政年份:2009
- 资助金额:
$ 78.76万 - 项目类别:
相似国自然基金
无线供能边缘网络中基于信息年龄的能量与数据协同调度算法研究
- 批准号:62372118
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CHCHD2在年龄相关肝脏胆固醇代谢紊乱中的作用及机制
- 批准号:82300679
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
颗粒细胞棕榈酰化蛋白FXR1靶向CX43mRNA在年龄相关卵母细胞质量下降中的机制研究
- 批准号:82301784
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
- 批准号:82301217
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Executive functions in urban Hispanic/Latino youth: exposure to mixture of arsenic and pesticides during childhood
城市西班牙裔/拉丁裔青年的执行功能:童年时期接触砷和农药的混合物
- 批准号:
10751106 - 财政年份:2024
- 资助金额:
$ 78.76万 - 项目类别:
The Role of Dopamine in Cognitive Resilience to Alzheimer's Disease Pathology in Healthy Older Adults
多巴胺在健康老年人阿尔茨海默氏病病理认知弹性中的作用
- 批准号:
10678125 - 财政年份:2023
- 资助金额:
$ 78.76万 - 项目类别:
Hospice exposure and utilization among older African Americans with ADRD and their decisional support persons
患有 ADRD 的老年非洲裔美国人及其决策支持人员的临终关怀暴露和利用
- 批准号:
10679558 - 财政年份:2023
- 资助金额:
$ 78.76万 - 项目类别:
Behavioral and physiological measurements of hearing in mouse models of Alzheimer's Disease
阿尔茨海默病小鼠模型听力的行为和生理测量
- 批准号:
10647340 - 财政年份:2023
- 资助金额:
$ 78.76万 - 项目类别: